ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TECH Bio Techne Corporation

64.06
1.40 (2.23%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 973,784
Bid Price 63.34
Ask Price 64.83
News (1)
Day High 64.36

Low
51.79

52 Week Range

High
89.91

Day Low 62.33
Company Name Stock Ticker Symbol Market Type
Bio Techne Corporation TECH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.40 2.23% 64.06 16:03:50
Open Price Low Price High Price Close Price Prev Close
62.83 62.33 64.36 64.06 62.66
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,165 973,784 $ 63.96 $ 62,287,254 - 51.79 - 89.91
Last Trade Time Type Quantity Stock Price Currency
18:35:14 2 $ 64.61 USD

Bio Techne Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
10.07B 157.19M - 1.14B 285.26M 1.81 35.31
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bio Techne News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TECH Message Board. Create One! See More Posts on TECH Message Board See More Message Board Posts

Historical TECH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week62.4564.58561.7963.01981,3461.612.58%
1 Month70.7571.2761.1665.85965,725-6.69-9.46%
3 Months66.6878.74561.1669.711,065,234-2.62-3.93%
6 Months61.3778.74551.7967.741,149,5402.694.38%
1 Year77.9089.9151.7972.131,024,176-13.84-17.77%
3 Years108.6325135.962551.7980.52616,455-44.57-41.03%
5 Years47.86135.962538.792577.79441,00116.2033.85%

Bio Techne Description

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Your Recent History

Delayed Upgrade Clock